PharmacoCheck+ Pharmacogenetics Testing provides a comprehensive evaluation of genetic variants influencing drug-metabolizing enzymes and transporters, enabling clinicians to identify metabolizer status and personalize medication selection and dosing to reduce adverse drug reactions and improve therapeutic outcomes.
PreCheck Health Services’ Comprehensive Hereditary Cancer Panel (116 genes) delivers an advanced, evidence-based germline analysis that identifies the molecular drivers of inherited cancer risk across solid tumors, hematologic malignancies, and multisystem cancer syndromes—providing clinically actionable insights to guide early detection, optimized surveillance, targeted risk-reduction strategies, personalized treatment decisions, and family risk assessment.
PreCheck Health Services’ Comprehensive Immunology Panel (291 genes) provides an advanced, evidence-based immunogenetic analysis that identifies molecular drivers of inborn errors of immunity, dysregulated inflammation, autoimmune predisposition, and immunotherapy responsiveness—delivering clinically actionable insights to guide personalized diagnosis, treatment, and risk assessment across oncology, infectious disease, rheumatology, and internal medicine.
PreCheck Health Services’ Comprehensive Neurology Panel (203 genes) delivers an advanced, evidence-based neurogenetic analysis that identifies clinically actionable variants driving epilepsy, neuromuscular disorders, leukodystrophies, hereditary neuropathies, and neurodegenerative diseases—providing clinicians with precise molecular insights to guide diagnosis, treatment selection, long-term management, and family risk assessment.
At PreCheck Health Services Inc., our mission is to deliver uncompromising excellence in clinical diagnostics. As a CLIA-certified and CAP-accredited high-complexity molecular laboratory, we specialize in advanced genomic testing that supports early detection, precision treatment, and proactive disease management.
Comprehensive Diagnostics: Our laboratory provides a full spectrum of next-generation diagnostic solutions, including targeted panels, high-complexity genetic assays, and cancer profiling. We leverage state-of-the-art sequencing platforms and validated methodologies to ensure accurate, clinically meaningful results.
Specialized Molecular Profiling: We provide comprehensive characterization of hereditary and somatic mutations through NGS, real-time PCR, and quantitative molecular methods, offering high-sensitivity, high-specificity assays that support precise clinical decision-making.
Personalized Care: By integrating comprehensive genomic data with evidence-based clinical guidelines, we empower physicians to make informed decisions regarding diagnosis, targeted therapy selection, risk assessment, and long-term patient management. Our patient-centered approach ensures that each test result contributes to optimized and personalized care.
CLIA 10D2210020 | CAP 9101993
For more than a decade, PreCheck Health Services has led the way in early disease detection and prevention. Our heritage is rooted in an unchanging dedication to prioritize patient health above all else.
We place a high priority on ensuring our customers' satisfaction.
latest announcements and stay updated on our most recent developments.
.svg)
